Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 6:9:1001791.
doi: 10.3389/fsurg.2022.1001791. eCollection 2022.

Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database

Affiliations
Review

Analysis of prognostic factors of metastatic endometrial cancer based on surveillance, epidemiology, and end results database

Meng Zhang et al. Front Surg. .

Abstract

Objective: To explore the risk factors for survival and prognosis of patients with metastatic endometrial cancer and to build and verify a reliable prediction model.

Methods: We retrospectively analyzed patients diagnosed with metastatic endometrial cancer in the US Surveillance, Epidemiology, and End Results (SEER) database between January 2010 and December 2015. Univariate and multivariate Cox regression analyses were used to assess clinical variables impact on survival and to construct nomograms. The results of the consistency index (C-index), subject operating characteristic (ROC) curve, and calibration curve were used to evaluate the predictive ability of the nomogram.

Results: This study included 3,878 patients with metastatic endometrial cancer. In the univariate analysis, variables associated with overall survival (OS) and cancer-specific survival (CSS) included age, race, marital status, pathological type, pathological grade, T-stage, N-stage, surgery, radiotherapy, chemotherapy, bone metastasis, brain metastasis, liver metastasis, and lung metastasis. In the multivariate analysis, age, race, pathological type, pathological grade, T-stage, N-stage, surgery, radiotherapy, chemotherapy, brain metastasis, liver metastasis, and lung metastasis were independent risk factors for OS and CSS (all P < 0.05). Combined with the results of the multiple factors, the 1-, 3-, 5-, and 8-year nomograms were constructed. For OS and CSS, T-stage had the greatest impact on the adverse prognosis of patients with metastatic endometrial cancer. The C-indexes of the OS and CSS nomograms in the training cohort were 0.749 (95% CI, 0.739-0.760) and 0.746 (95% CI, 0.736-0.756), respectively. The C-indices of OS and CSS in the validation cohort were 0.730 (95% CI, 0.714-0.746) and 0.728 (95% CI, 0.712-0.744), respectively. The ROC curve revealed our model's good prediction accuracy and clinical practicability. The calibration curve also confirmed the consistency between the model and actual existence. The Kaplan-Meier curves revealed statistically significant differences between the risk subgroups (P < 0.05).

Conclusion: Our SEER-based nomograms for predicting survival in patients with metastatic endometrial cancer were helpful for the clinical evaluation of patient prognosis.

Keywords: SEER database; endometrial cancer; metastasis; nomogram; predictive model fund program: natural science foundation of gansu province(17JR5RA242).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart for screening patients with metastatic endometrial cancer.
Figure 2
Figure 2
Nomograms of metastatic endometrial cancer to predict 1-,3-,5- and 8-year survival rates (A) OS and (B) CSS.
Figure 3
Figure 3
ROC curves of the nomograms for predicting CSS and OS at 1-,3-,5- and 8-year point. (A–H) the training cohort; (I–P) the validation cohort.
Figure 4
Figure 4
Calibration plots for predicting OS and CSS at 1-,3-,5- and 8-year. (A–H) the training cohort; (I–P) the validation cohort.
Figure 5
Figure 5
The risk stratification system constructed by Kaplan-Meier survival analysis in the validation cohort. (A–D) OS; (E–H) CSS.

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. (2013) 63(1):11–30. 10.3322/caac.21166 - DOI - PubMed
    1. Takenaka k, Curry-Hyde A, Olzomer EM, Farrell R, Byrne FL, Janitz M, et al. Investigation of Transcriptome Patterns in Endometrial Cancers from Obese and Lean Women. Int J Mol Sci. 2022. Sep 29 23(19):11471. 10.3390/ijms231911471 - DOI - PMC - PubMed
    1. Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer. (2016) 26(1):2–30. 10.1097/IGC.0000000000000609 - DOI - PMC - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. (2022) 72(1):7–33. 10.3322/caac.21708 - DOI - PubMed
    1. Garg V, Jayaraj AS, Kumar L. Novel approaches for treatment of endometrial carcinoma. Curr Probl Cancer. (2022) 46(5):100895. 10.1016/j.currproblcancer.2022.100895 - DOI - PubMed

LinkOut - more resources